Bruce Sands

35PUBLICATIONS
211CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)RehabilitationForest health and pathologyHorticultural crop improvement (incl. selection and breeding)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|May 25, 2026
Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

|May 05, 2026
Improvement in Health-Related Quality of Life in Patients with Moderate to Severe Crohn's Disease Treated with Risankizumab vs Ustekinumab in the Phase 3B SEQUENCE Study.

|May 01, 2026
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial.

|May 01, 2026
Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension Study.

|Apr 15, 2026
Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials.

|Mar 30, 2026
Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial.

Stefan Schreiber, Bruce E Sands, Silvio Danese

Pageof 6

Frequent Collaborators

12 joint publications

Silvio Danese

6 joint publications

Laurent Peyrin-Biroulet

6 joint publications

Jean-Frédéric Colombel

5 joint publications

Edward V Loftus